ADVERTISEMENT

Conference Report

ASCO 2022 – Do we really need stem cell transplant in newly diagnosed multiple myeloma?

Cristina Ferrario — Agenzia Zoe   |   08 June 2022

Takeaway

  • In younger, newly diagnosed multiple myeloma (NDMM) patients, early use of autologous stem cell transplant (ASCT) led to significant gains in progression-free survival (PFS) compared to the absence of an initial transplant.
  • ASCT timing did not influence the overall survival (OS).
  • Adverse events are more common with ASCT.

 ...

          

November Challenge

Ends in 1d 7h
left
right

Topic Challenges

left
right